Manzo Pharmaceuticals Announces Positive Results from Laboratory Study of Lacto-Freedom Probiotic
Manzo Pharmaceuticals, Inc. (OTCPink:MNZO), today announced positive results from the six month animal study of Lacto-Freedom™, the company's lactase producing probiotic. This successful testing brings Manzo Pharmaceuticals, and partner, Celprogen, Inc., one step closer to human clinical trials.